1 report

  • Jenrin Discovery, Inc. - Research and Development Overview
  • JD-3000 Series

JD-## acts as a cannabinoid receptor type ## (CB##) antagonist.

  • Obesity
  • Pathology
  • Research And Development
  • Therapy
  • Jenrin Discovery, Inc.